Study population
ascites, peritoneal cancer, Fifty‐seven, Ascites
ASCITES, PERITONEAL CANCER, ASCITES, MAY, CAVITY, ONCOLOGY
Between January 2017 and May 2019, 57 patients were recruited. 8 patients were excluded and 49 eligible patients were finally enrolled in the study (Figure Trail profile at the cutoff date for analysis. Fifty‐seven patients were assessed and 49 patients were enrolled. Forty‐seven patients were included in the survival analysis and two patients were excluded because they did not receive an efficacy evaluation.Characteristics of patients (Abbreviations: ECOG PS, Eastern Cooperative Oncology Group performance status; IQR, interquartile range; PCI, peritoneal cancer index; sPCI, PCI was calculated using laparoscopy or surgery record.Ascites were evaluated by computed tomography or laparoscopy: small indicates ascites within the pelvic cavity; moderate indicates ascites beyond the pelvic cavity.